Table 1 Comparison of general data between the two groups
Group | |||
|---|---|---|---|
CTG (n = 137) | CPRNG (n = 132) | P | |
Age group | |||
40–49 years | 7(5.11%) | 4(3.03%) | 0.58 |
50–59 years | 37(27.01%) | 36(27.28%) | 1 |
60–69 years | 45(32.85%) | 42(31.82%) | 0.96 |
70 years and older | 48(35.04%) | 50(37.88%) | 0.72 |
Gender | |||
Female | 39(28.47%) | 37(28.03%) | 1 |
Male | 98(71.53%) | 95(71.98%) | 1 |
Time since diagnosis | |||
1–4 years | 53(38.69%) | 45(32.85%) | 0.51 |
5–9 years | 39(28.47%) | 42(31.82%) | 0.64 |
10 years + | 45(32.85%) | 45(32.85%) | 0.93 |
Smoking status | |||
Smoker | 17(12.41%) | 17(12.88%) | 1 |
Ex-smoker | 104(75.91%) | 102(77.27%) | 0.9 |
Non-smoker | 16(11.68%) | 17(12.88%) | 0.9 |
Alcohol drinking status | |||
Ex-drinker | 78(56.93%) | 80(60.60%) | 0.62 |
Non-drinker | 59(43.07%) | 52(39.40%) | 1 |
The most common problems | |||
Shortness of breath | 69(50.36%) | 66(50.00%) | 1 |
Cough | 45(32.85%) | 43(32.58%) | 1 |
Phlegm | 39(28.47%) | 37(28.03%) | 1 |
Fatigue | 49(35.78%) | 45(32.85%) | 0.87 |
Insomnia | 28(20.44%) | 26(19.70%) | 1 |
Wheezing | 17(12.41%) | 17(12.88%) | 1 |
Sweating | 7(5.11%) | 8(6.06%) | 0.94 |
Pharmacological Treatment | |||
LAMA (%) | 118 (86.1%) | 116 (87.9%) | 0.68 |
LABA (%) | 105 (76.6%) | 103 (78.0%) | 0.78 |
ICS (%) | 92 (67.2%) | 91 (68.9%) | 0.75 |
LAMA + LABA (%) | 97 (70.8%) | 95 (72.0%) | 0.82 |
LAMA + ICS (%) | 85 (62.0%) | 83 (62.9%) | 0.91 |
LABA + ICS (%) | 80 (58.4%) | 79 (59.8%) | 0.84 |
LAMA + LABA + ICS (%) | 74 (54.0%) | 72 (54.5%) | 0.94 |